EUVIMEDEUVIMED entdecken
Open Access

Effects of Alendronate and Alfacalcidol on Preventing Bone Loss in Chemotherapy-treated Soft-tissue Sarcoma

Manami Nakanishi, Hiroyuki Tsuchie, Hiroyuki Nagasawa, Michio Hongo, Yuji Kasukawa, Koji Nozaka, Takashi Kawaragi, Manabu Watanabe, Yasuhito Asaka, Y O Morishita, Naohisa Miyakoshi

In Vivo · 2026-11 · 40 (6) · 3311-3321

DOI: 10.21873/invivo.14479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, online erschienen am 29.10.2026. Verfasst von Manami Nakanishi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan; mnakanishi@med.akita-u.ac.jp. Hauptthemen laut MEDLINE: Alendronate, Hydroxycholecalciferols, Sarcoma, Bone Density Conservation Agents. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlendronateHydroxycholecalciferolsSarcomaBone Density Conservation AgentsBone ResorptionAnimalsFemaleMiceDoxorubicinRANK LigandDisease Models, AnimalCell Line, TumorCore Binding Factor Alpha 1 SubunitX-Ray MicrotomographyBiomarkers

Stichwörter der Autor:innen

CTIBLOsteoporosisalendronatealfacalcidoldoxorubicinsoft-tissue sarcoma mouse model

Substanzen

AlendronatealfacalcidolHydroxycholecalciferolsDoxorubicinRANK LigandBone Density Conservation AgentsCore Binding Factor Alpha 1 SubunitBiomarkers

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan; mnakanishi@med.akita-u.ac.jp.
  • Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Department of Orthopedic Surgery, Noshiro Kousei Medical Center, Akita, Japan.
  • Department of Orthopedic Surgery, Akita Rosai Hospital, Akita, Japan.

Zitieren

APA

Nakanishi, M., Tsuchie, H., Nagasawa, H., Hongo, M., Kasukawa, Y., Nozaka, K., Kawaragi, T., Watanabe, M., Asaka, Y., Morishita, Y. O., & Miyakoshi, N. (2026). Effects of Alendronate and Alfacalcidol on Preventing Bone Loss in Chemotherapy-treated Soft-tissue Sarcoma. In Vivo, 40(6), 3311-3321. https://doi.org/10.21873/invivo.14479

Vancouver

Nakanishi M, Tsuchie H, Nagasawa H, Hongo M, Kasukawa Y, Nozaka K, et al. Effects of Alendronate and Alfacalcidol on Preventing Bone Loss in Chemotherapy-treated Soft-tissue Sarcoma. In Vivo. 2026;40(6):3311-3321. doi:10.21873/invivo.14479

BibTeX
@article{Nakanishi2026,
  author = {Nakanishi, Manami and Tsuchie, Hiroyuki and Nagasawa, Hiroyuki and Hongo, Michio and Kasukawa, Yuji and Nozaka, Koji and Kawaragi, Takashi and Watanabe, Manabu and Asaka, Yasuhito and Morishita, Y O and Miyakoshi, Naohisa},
  title = {Effects of Alendronate and Alfacalcidol on Preventing Bone Loss in Chemotherapy-treated Soft-tissue Sarcoma},
  journal = {In Vivo},
  year = {2026},
  volume = {40},
  number = {6},
  pages = {3311--3321},
  doi = {10.21873/invivo.14479}
}
Kostenlos starten →